Lifecore Biomedical
Open
$5.09
Prev. Close
$5.07
High
$5.09
Low
$5.07
Market Snapshot
$185.08M
-5.0
-0.51
$130.86M
406
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 406 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
emptyResult
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 406 full-time employees. The firm designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The firm offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. The company is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The firm uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Recently from Cashu
Lifecore Biomedical Reports 9.8% Revenue Growth in Fourth Quarter, Meeting Analyst Expectations
Lifecore Biomedical Reports Strong Fourth-Quarter Revenue Growth Lifecore Biomedical delivers encouraging news in its latest fourth-quarter financial report, revealing a revenue of $35.7 million for t…
Lifecore Biomedical Reports 9.8% Revenue Growth in Strong Fourth Quarter Performance
Lifecore Biomedical’s Fourth-Quarter Performance Illustrates Ongoing Growth Lifecore Biomedical’s recent fourth-quarter report reveals a noteworthy achievement, as the company records a revenue of $35…
Lifecore Biomedical Reports 9.8% Revenue Growth in Fourth Quarter Amid Market Competition
Lifecore Biomedical's Fourth-Quarter Performance Reflects Steady Growth Amid Competitive Landscape In its recent fourth-quarter report, Lifecore Biomedical reveals a revenue of $35.7 million, marking…
Lifecore Biomedical Posts 9.8% Revenue Growth in Strong Fourth Quarter Performance
Lifecore Biomedical Reports Strong Fourth-Quarter Performance Lifecore Biomedical has recently announced its fourth-quarter earnings, reporting a revenue of $35.7 million, a notable year-over-year inc…